|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
2004-8-4
|
|
pubmed:abstractText |
The intent of this study was to compare the efficacy and safety of fluoxetine, olanzapine, or the olanzapine-fluoxetine combination (OFC) in the treatment of women meeting criteria for borderline personality disorder (without concurrent major depressive disorder).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
0160-6689
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
65
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
903-7
|
|
pubmed:dateRevised |
2008-11-21
|
|
pubmed:meshHeading |
pubmed-meshheading:15291677-Adolescent,
pubmed-meshheading:15291677-Adult,
pubmed-meshheading:15291677-Aggression,
pubmed-meshheading:15291677-Antipsychotic Agents,
pubmed-meshheading:15291677-Benzodiazepines,
pubmed-meshheading:15291677-Borderline Personality Disorder,
pubmed-meshheading:15291677-Depressive Disorder,
pubmed-meshheading:15291677-Drug Combinations,
pubmed-meshheading:15291677-Drug Therapy, Combination,
pubmed-meshheading:15291677-Female,
pubmed-meshheading:15291677-Fluoxetine,
pubmed-meshheading:15291677-Humans,
pubmed-meshheading:15291677-Impulsive Behavior,
pubmed-meshheading:15291677-Psychiatric Status Rating Scales,
pubmed-meshheading:15291677-Regression Analysis,
pubmed-meshheading:15291677-Serotonin Uptake Inhibitors,
pubmed-meshheading:15291677-Treatment Outcome
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
A preliminary, randomized trial of fluoxetine, olanzapine, and the olanzapine-fluoxetine combination in women with borderline personality disorder.
|
|
pubmed:affiliation |
Laboratory for the Study of Adult Development, McLean Hospital, Belmont, MA 02478, USA. zanarini@mclean.harvard.edu
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial
|
